Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Different profiles of chemokines, cytokines and cell growth factors in plasma samples from patients with leprosy, leprosy reactions and households contacts.

de Carvalho J, Pascoal-Xavier M, Araújo M, et al. Memorias do Instituto Oswaldo Cruz. 2024;
Download PDF
Publication

GPZL: New Strategy 2024-2026

Global Partnership for Zero Leprosy . 2023;
Download PDF
Publication

Feasibility of post-exposure-prophylaxis with single-dose rifampicin and identification of high prevalent clusters in villages' hyperendemic for leprosy in Senegal.

Batista G, Dioussé P, Diagne P, et al. PLoS neglected tropical diseases. 2024; 18 (2) : 1-10.
Download PDF
Publication

Determining Factors Of Leprosy: A Case-Control Study In A Hyperendemic Area Of The Brazilian Legal Amazon

Novais DG, Barbosa SM, Mariano WDS, et al. PPUFU - Portal de Periódicos da Universidade Federal de Uberlândia. Hygeia - Revista Brasileira de Geografia Médica e da Saúde. 2024;
Download PDF
Publication

Positive Correlation of Plasma Interleukin-6 Levels with Immunoglobulin M (IgM) Anti Phenolic Glycolipid-1 (PGL-1) Levels in Household Contacts of Multibacillary Leprosy Patients

Pratama N, Mas Rusyati LM, Vibriyanti Karma NLPR. Galore Knowledge Publication Pvt. Ltd.. International Journal of Research and Review. 2023; 10 (4) : 144-151.
Download PDF
Publication

A Comparison of Cathelicidin Levels in the Skin of Leprosy Patients and Their Household Contacts

Argentina F, Suwarsa O, Gunawan H, et al. Academy of Sciences and Arts of Bosnia and Herzegovina. Acta Medica Academica. 2023;
Download PDF
Publication

A cost-effectiveness analysis of a novel algorithm to sequentially diagnose leprosy based on manufactured tests under the SUS perspective.

da Costa M, Magliano C, Barros B, et al. Cadernos de saude publica. 2024; 40 (1) : 1-13.
Download PDF
Publication

Association of PTX3 gene polymorphisms and PTX3 plasma levels with leprosy susceptibility.

Moraes A, da Luz R, Fernandes A, et al. BMC infectious diseases. 2023; 23 (1) : 1-7.
Download PDF
Publication

Specialized active leprosy search strategies in an endemic area of the Brazilian Amazon identifies a hypermutated strain causing primary drug resistance.

Bouth R, Gobbo A, Barreto J, et al. Frontiers in medicine. 2023;
Download PDF
Publication

Introduction to Hansen’s Disease

Florian MC, Da Cunha Lopes Virmond M, Deps PD. Springer International Publishing. Hansen’s Disease. 2023;

Pagination

  • Previous page ‹‹
  • Page 3
  • Next page ››
Subscribe to Contacts / Contact tracing

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD